{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:55:42Z","timestamp":1792065342397,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.phrs.2016.11.028","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T23:18:02Z","timestamp":1480029482000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Passive drug permeation through membranes and cellular distribution"],"prefix":"10.1016","volume":"117","author":[{"given":"D.O.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15\u201316","key":"10.1016\/j.phrs.2016.11.028_bib0005","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.drudis.2012.03.015","article-title":"Evidence-based approach to assess passive diffusion and carrier-mediated drug transport","volume":"17","author":"Di","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.phrs.2016.11.028_bib0010","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrd3187","article-title":"Coexistence of passive and carrier-mediated processes in drug transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.028_bib0015","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2016.11.028_bib0020","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Membrane transporters and drug response","author":"Giacomini","year":"2013"},{"issue":"15\/16","key":"10.1016\/j.phrs.2016.11.028_bib0025","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.drudis.2011.05.010","article-title":"Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only","volume":"16","author":"Kell","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.028_bib0030","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1124\/dmd.110.035998","article-title":"Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods","volume":"39","author":"Friden","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.028_bib0035","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.028_bib0040","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.028_bib0045","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00249-008-0338-4","article-title":"Quantitative modeling of selective lysosomal targeting for drug design","volume":"37","author":"Trapp","year":"2008","journal-title":"Eur. Biophys. J."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.028_bib0050","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2174\/156720509789207903","article-title":"Lysosomal modulatory drugs for a broad strategy against protein accumulation disorders","volume":"6","author":"Bahr","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.028_bib0055","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/cbic.200600149","article-title":"The consequences of lysosomotropism on the design of selective cathepsin K inhibitors","volume":"7","author":"Black","year":"2006","journal-title":"ChemBioChem"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.028_bib0060","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J. Med. Chem."},{"issue":"5332","key":"10.1016\/j.phrs.2016.11.028_bib0065","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH, and the antimalarial action of chloroquine","volume":"235","author":"Homewood","year":"1972","journal-title":"Nature (London)"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.028_bib0070","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0166-6851(85)90058-1","article-title":"Primaquine and lysosomotropic amines inhibit malaria sporozoite entry into human liver cells","volume":"14","author":"Schwartz","year":"1985","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.028_bib0075","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.028_bib0080","doi-asserted-by":"publisher","first-page":"e35949","DOI":"10.1371\/journal.pone.0035949","article-title":"Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin","volume":"7","author":"Swietach","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.028_bib0085","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ps.2780190203","article-title":"Physico-chemical factors affecting uptake by roots and translocation to shoots of weak acids in barley","volume":"19","author":"Briggs","year":"1987","journal-title":"Pestic. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.028_bib0090","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1104\/pp.86.3.803","article-title":"Phloem mobility of xenobiotics. I. Mathematical model unifying the weak acid and intermediate permeability theories","volume":"86","author":"Kleier","year":"1988","journal-title":"Plant Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.028_bib0095","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1021\/ac300016n","article-title":"Permeation of a fully ionized species across a polarized supported liquid membrane","volume":"84","author":"Velicky","year":"2012","journal-title":"Anal. Chem. (Washington, DC, US)"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.028_bib0100","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ac402328w","article-title":"Mechanism of ion transfer in supported liquid membrane systems: electrochemical control over membrane distribution","volume":"86","author":"Velicky","year":"2014","journal-title":"Anal. Chem. (Washington, DC, US)"},{"issue":"31","key":"10.1016\/j.phrs.2016.11.028_bib0105","doi-asserted-by":"publisher","first-page":"32367","DOI":"10.1074\/jbc.M400735200","article-title":"Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60","volume":"279","author":"Duvvuri","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2016.11.028_bib0110","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.phrs.2016.11.028_bib0115","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2174\/1381612811319150015","article-title":"Novel penetrating cations for targeting mitochondria","volume":"19","author":"Chernyak","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl","key":"10.1016\/j.phrs.2016.11.028_bib0120","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.mito.2007.02.007","article-title":"Mitochondrial targeting of quinones: therapeutic implications","volume":"7","author":"Cocheme","year":"2007","journal-title":"Mitochondrion"},{"issue":"20","key":"10.1016\/j.phrs.2016.11.028_bib0125","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.2174\/0929867322666150209155957","article-title":"Shutting down the furnace: preferential killing of cancer cells with mitochondrial-targeting molecules","volume":"22","author":"Deus","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.028_bib0130","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1124\/dmd.114.058032","article-title":"Toward a unified model of passive drug permeation II: the physiochemical determinants of unbound tissue distribution with applications to the design of hepatoselective glucokinase activators","volume":"42","author":"Ghosh","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.028_bib0135","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1124\/dmd.115.066647","article-title":"Rapid method to determine intracellular drug concentrations in cellular uptake assays: application to metformin in organic cation transporter 1-transfected human embryonic kidney 293 cells","volume":"44","author":"Chien","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.11.028_bib0140","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejps.2013.10.004","article-title":"Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation","volume":"52","author":"Ghosh","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.028_bib0145","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00249-005-0472-1","article-title":"A predictive model for the selective accumulation of chemicals in tumor cells","volume":"34","author":"Trapp","year":"2005","journal-title":"Eur. Biophys. J."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.028_bib0150","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrm2820","article-title":"Sensors and regulators of intracellular pH","volume":"11","author":"Casey","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2016.11.028_bib0155","series-title":"Essentials of Medical Biochemistry","author":"Ha","year":"2011"},{"issue":"8","key":"10.1016\/j.phrs.2016.11.028_bib0160","first-page":"972","article-title":"In situ measurement of the electrical potential across the lysosomal membrane using FRET","volume":"12","author":"Koivusalo","year":"2011","journal-title":"Traffic (Oxford, UK)"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.028_bib0165","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2144\/000113610","article-title":"Mitochondrial membrane potential probes and the proton gradient: a practical usage guide","volume":"50","author":"Perry","year":"2011","journal-title":"Biotechniques"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.028_bib0170","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0005-2736(92)90314-C","article-title":"Measurement of plasma membrane potential in isolated rat hepatocytes using the lipophilic cation, tetraphenylphosphonium: correction of probe intracellular binding and mitochondrial accumulation","volume":"1111","author":"Saito","year":"1992","journal-title":"Biochim. Biophys. Acta: Biomembr."},{"issue":"5, Pt. 1","key":"10.1016\/j.phrs.2016.11.028_bib0175","first-page":"G826","article-title":"Voltage-driven, taurocholate-dependent secretion in isolated hepatocyte couplets","volume":"256","author":"Weinman","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.028_bib0180","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejps.2004.11.011","article-title":"Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKfluxa method","volume":"24","author":"Avdeef","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.028_bib0185","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/mp4000822","article-title":"Rapid measurement of intracellular unbound drug concentrations","volume":"10","author":"Mateus","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.028_bib0190","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/bdd.1823","article-title":"Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption","volume":"34","author":"Shitara","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.028_bib0195","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1124\/dmd.111.040477","article-title":"Kinetic characterization of rat hepatic uptake of 16 actively transported drugs","volume":"39","author":"Yabe","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.028_bib0200","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1124\/dmd.108.026377","article-title":"Development of a high-throughput brain slice method for studying drug distribution in the central nervous system","volume":"37","author":"Friden","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.028_bib0205","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1124\/dmd.105.007914","article-title":"Evaluation of the utility of brain slice methods to study brain penetration","volume":"34","author":"Becker","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.028_bib0210","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2045-8118-10-6","article-title":"The brain slice method for studying drug distribution in the CNS","volume":"10","author":"Loryan","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.028_bib0215","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1071\/CH11132","article-title":"Recent advances in mapping the sub-cellular distribution of metal-based anticancer drugs","volume":"64","author":"Wedlock","year":"2011","journal-title":"Aust. J. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.028_bib0220","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nchem.1961","article-title":"Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering","volume":"6","author":"Fu","year":"2014","journal-title":"Nat. Chem."},{"key":"10.1016\/j.phrs.2016.11.028_bib0225","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.talanta.2015.05.017","article-title":"Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC-MS\/MS","volume":"144","author":"Yuan","year":"2015","journal-title":"Talanta"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T23:24:52Z","timestamp":1568589892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"alternative-id":["S1043661816305606"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.028","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive drug permeation through membranes and cellular distribution","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}